Blood neurofilament light chain at the doorstep of clinical application
- PMID: 31516914
- PMCID: PMC6705620
- DOI: 10.1212/NXI.0000000000000599
Blood neurofilament light chain at the doorstep of clinical application
Figures
Comment on
-
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.Neurol Neuroimmunol Neuroinflamm. 2019 Aug 8;6(5):e598. doi: 10.1212/NXI.0000000000000598. eCollection 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31516913 Free PMC article. Clinical Trial.
References
-
- Barro C, Benkert P, Grobke S, et al. . Serum neurofilament light chain correlates with disease activity and predicts clinical and MRI outcomes in MS. Mult Scler J 2017;23:297–298.
-
- Berger T, Stuve O. Neurofilament light chain: an important step toward a disease biomarker in multiple sclerosis. Neurology 2019;92:451–452. - PubMed
-
- Khalil M, Teunissen CE, Otto M, et al. . Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 2018;14:577–589. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources